SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Other Financing Activities

Financing cash flows not reported separately.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026

Other financing activities of $0 in Q1 FY2026

Q1 FY2026 other financing activities was $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0+100.0% QoQ
Last fiscal yearDec 2025
-$1.47M— YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Financing Activities history

USD · from the cash flow

Latest · FY2025
(1.47M) USD
Year-over-year change
—

Other Financing Activities vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Other Financing Activities for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$649.76M USD+380.0%+77.4%5.9%
GKOSGlaukos CorporationLTM Jun 2026$12.9M USD-70.4%+49.6%2.1%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$3.59M USD-136.4%-24.2%47.2%
STAASTAAR Surgical CompanyLTM Apr 2026$2.73M USD+11.6%—0.9%
SGPSpyGlass Pharma, Inc. Common StockFY2025$1.47M USD———
OCSOculis Holding AGLTM Mar 2026CHF 1.02M CHF-107.2%—202.6%
RXSTRxSight, Inc.LTM Mar 2026$951K USD+189.4%+14.5%0.7%
BLCOBausch + Lomb CorporationLTM Jun 2026$499.55K USD-98.7%-78.4%0.0%
SGHTSight Sciences, Inc.LTM Mar 2026$5K USD+101.6%—0.0%
OCULOcular Therapeutix, Inc.LTM Mar 2026$0 USD-100.0%—0.0%
Peer median (excluding SGP) —-70.4%+14.5%0.9%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.